Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
Oncotarget|October 27, 2015
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathwayTong Liu, Kebang Hu, Zuowei Zhao, et al.Elife|March 14, 2023
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trialCaigang Liu, Hong Yu, Guanglei Chen, et al.Elife|October 27, 2023
Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphomaHe Liu, Meisuo Liu, Xibao Tian, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2023
Oleic Acid Dissolves cGAS-DNA Phase Separation to Inhibit Immune SurveillanceLina Wang, Qiaoling Liu, Na Wang, et al.Oncotarget|October 6, 2017
Prognostic significance of GSTP1 in patients with triple negative breast cancerGuanglei Chen, Hao Zhang, Lisha Sun, et al.Nature Communications|November 19, 2022
DNA mechanical flexibility controls DNA potential to activate cGAS-mediated immune surveillanceLina Wang, Siru Li, Kai Wang, et al.Cell Communication and Signaling : CCS|May 29, 2019
Crystal structure of a cytocidal protein from lamprey and its mechanism of action in the selective killing of cancer cellsYue Pang, Meng Gou, Kai Yang, et al.BMC Cancer|July 5, 2018
Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clusteringZhiqiong Wang, Mo Li, Zhen Xu, et al.International Journal of Medical Sciences|November 9, 2020
HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patientsXudong Zhu, Yixiao Zhang, Yang Bai, et al.Elife|January 5, 2023
Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancerJiawen Bu, Yixiao Zhang, Nan Niu, et al.Pageof 13